Immupharma (IMM)

 

IMM Share PerformanceMore

52 week high70.32 17/02/17
52 week low24.50 20/04/16
52 week change 26.51 (98.17%)
4 week volume7,626,782 26/02/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

ImmuPharma to present at Master Investor Show

RNS Number: 3981A Immupharma PLC 24 March 2017 24 MARCH 2017 IMMUPHARMA'S CHAIRMAN TO PRESENT AT MASTER INVESTOR SHOW Date: Saturday 25 March 2017, Business Design Centre, Islington ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, confirms that Tim...

Holding(s) in Company

RNS Number: 1863A Immupharma PLC 22 March 2017 22 MARCH 2017 NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Alto Invest ("Alto") confirming its holding in ImmuPha...

Holding(s) in Company

RNS Number: 9558Z Immupharma PLC 20 March 2017 20 MARCH 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") TR1 NOTIFICATION OF MAJOR INTEREST ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, announces that it has today received a TR-1 by Aviva plc ("Aviva"). Aviva's holding in ImmuPhar...

Holding(s) in Company

RNS Number: 8768Z Immupharma PLC 20 March 2017 20 MARCH 2017 NOTIFICATION OF MAJOR INTEREST BY LEGAL & GENERAL ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc ("L&G") confirming...

?4.1 Million Fund Raise via Accelerated Bookbuild

RNS Number: 1934Z Immupharma PLC 10 March 2017 10 March 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Successful 4.1 Million Fund Raise Following the Close of the Accelerated Bookbuild ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to announce that further to the announcement made ea...

Accelerated Bookbuild for the Issue of Equity

RNS Number: 0838Z Immupharma PLC 10 March 2017 10 March 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Accelerated Bookbuild for the Issue of Equity ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to announce a proposed placing, raising a minimum of 3 million (before expenses), via the is...

Holding(s) in Company

RNS Number: 6574Y Immupharma PLC 06 March 2017 6 March 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Holding(s) in Company ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, has received notification that Alto Invest now holds 4,969,543 ordinary shares of 10p each in the Company, representing 3.99%...

Holding(s) in Company

RNS Number: 2167X Immupharma PLC 17 February 2017 17 FEBRUARY 2017 NOTIFICATION OF INTEREST BY LEGAL & GENERAL ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc ("L&G") confirming its...

Fundamental DataMore

EPS-4.4
Dividend yield0 %

Latest discussion posts More

  • Re: 9.5% rise...

    This placing not mentioned on share prophets site ,daily market news ( 10.30 am ) .. they don't post all.
    10-Mar-2017
    Ripley94
  • Re: 9.5% rise...

    Very quite board . No mention of placing @ 35p 21/10/2016. 1 mil raise Another RNS today further placing @ 52p. 2m to 5m raise.
    10-Mar-2017
    Ripley94
  • Re: 9.5% rise...

    N/C. 19/09/12. ( 53 ) 24/10/12.
    9-Mar-2017
    Ripley94

Users' HoldingsMore

Users who hold Immupharma also hold..
LLOYDS GRP.29%
BP17%
NATIONAL GRID16%
GLAXOSMITHKLINE13%
ROYAL BANK SCOT13%

Codes & Symbols

ISINGB0033711010
SymbolsIMM, LSE:IMM, IMM.L, IMM:LN, LON:IMM, XLON:IMM